Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Apr 29:9:813169.
doi: 10.3389/fbioe.2021.813169. eCollection 2021.

Strategies for Biomaterial-Based Spinal Cord Injury Repair via the TLR4-NF-κB Signaling Pathway

Affiliations
Review

Strategies for Biomaterial-Based Spinal Cord Injury Repair via the TLR4-NF-κB Signaling Pathway

Bin Lv et al. Front Bioeng Biotechnol. .

Abstract

The repair and motor functional recovery after spinal cord injury (SCI) has remained a clinical challenge. Injury-induced gliosis and inflammation lead to a physical barrier and an extremely inhibitory microenvironment, which in turn hinders the recovery of SCI. TLR4-NF-κB is a classic implant-related innate immunomodulation signaling pathway and part of numerous biomaterial-based treatment strategies for SCI. Numerous experimental studies have demonstrated that the regulation of TLR4-NF-κB signaling pathway plays an important role in the alleviation of inflammatory responses, the modulation of autophagy, apoptosis and ferroptosis, and the enhancement of anti-oxidative effect post-SCI. An increasing number of novel biomaterials have been fabricated as scaffolds and carriers, loaded with phytochemicals and drugs, to inhibit the progression of SCI through regulation of TLR4-NF-κB. This review summarizes the empirical strategies for the recovery after SCI through individual or composite biomaterials that mediate the TLR4-NF-κB signaling pathway.

Keywords: TLR4-NF-κB; autophagy; biomaterial; signaling pathway; spinal cord injury.

PubMed Disclaimer

Conflict of interest statement

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

FIGURE 1
FIGURE 1
The role of TLR4-NF-κB signaling pathway in modulating inflammation, autophagy and apoptosis. TLR4 activates transcription factor NF-κB through MyD88-dependent/TRIF-dependent signaling pathways respectively, thus up-regulating the expression of inflammatory mediators and chemokines, and exacerbating neuroinflammation. However, the TLR4-NF-κB signaling pathway can be inhibited by certain kinds of miRNAs. In addition, NF-κB imparts reciprocal regulation with TNF-α. Activated NF-κB regulates TNF-α homeostasis, and TNF-α in turn activates NF-κB via TRADD/TRAF2/MAPK signaling pathway and promotes apoptosis through TRADD/FADD/caspase8 pathway. On the other hand, the TLR4/MAPK-P38 pathway plays an important role in the regulation of inflammation and autophagy, eliciting innate immune responses.
FIGURE 2
FIGURE 2
Hydrogel as a stent repair strategy for spinal cord injury.
FIGURE 3
FIGURE 3
Schematic diagram of curcumin encapsulated in hydrogel for central nervous system injury.

References

    1. Abbas W. A., Ibrahim M. E., El-Naggar M., Abass W. A., Abdullah I. H., Awad B. I., et al. (2020). Recent Advances in the Regenerative Approaches for Traumatic Spinal Cord Injury: Materials Perspective. ACS Biomater. Sci. Eng. 6, 6490–6509. 10.1021/acsbiomaterials.0c01074 - DOI - PubMed
    1. Abbaszadeh F., Fakhri S., Khan H. (2020). Targeting Apoptosis and Autophagy Following Spinal Cord Injury: Therapeutic Approaches to Polyphenols and Candidate Phytochemicals. Pharmacol. Res. 160, 105069. 10.1016/j.phrs.2020.105069 - DOI - PubMed
    1. Adil M. M., Vazin T., Ananthanarayanan B., Rodrigues G. M. C., Rao A. T., Kulkarni R. U., et al. (2017). Engineered Hydrogels Increase the post-transplantation Survival of Encapsulated hESC-Derived Midbrain Dopaminergic Neurons. Biomaterials 136, 1–11. 10.1016/j.biomaterials.2017.05.008 - DOI - PubMed
    1. Akira S., Takeda K. (2004). Toll-like Receptor Signalling. Nat. Rev. Immunol. 4, 499–511. 10.1038/nri1391 - DOI - PubMed
    1. Akira S., Uematsu S., Takeuchi O. (2006). Pathogen Recognition and Innate Immunity. Cell 124, 783–801. 10.1016/j.cell.2006.02.015 - DOI - PubMed

LinkOut - more resources